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Typical atrioventricular (AV) node re-entrant tachycardia (AVNRT) occurs
in patients with dual AV nodal pathway, a rapid pathway used for retrograde
conduction and a slow pathway used for the anterograde conduction. In sinus
rhythm, the patients have generally the signs of conduction through the rapid
pathway with a normal or short PR interval. The purpose of the study was to
evaluate the prevalence of patients with 1st degree AV block and with AVNRT
and their clinical characteristics.
Methods: 973 patients, 348 males, 625 females, were admitted for typical
AVNRT. They were aged from 6 to 90 years (mean age 50±19). Initial ECG
and clinical data were collected. Electrophysiological study was systematic.
Results: Spontaneous 1st degree AV block (AVB) was rare and noted in
7 patients. The prevalence of the association 1st degree AV block and AVNRT
was 0.7%. Five patients complained of AVNRT at exercise. Two patients had
an ischemic heart disease. Patients with AVB were significantly older (71.5±
16 years) than patients without AVB (50±19)(p<0.002). AVNRT was induced
in control state in 4 patients. The rate of tachycardia was slow between 130 and
150 bpm. AVNRT was induced after isoproterenol in 3 patients and the rate
was higher (180 to 200 bpm). Ablation of slow pathway was performed in
6 patients. Transitory 2nd degree AVB was noted in 1 patient. AVNRT was not
inducible after ablation. PR interval remained unchanged. At atrial pacing, the
rate of 2nd degree AVB occurrence decreased, due to the disappearance of the
conduction through the slow pathway. Two patients developed transitory well-
tolerated 2nd degree AVB one day after ablation. One patient presented
apparent sinus bradycardia related to a concealed conduction through AV node.
One year after ablation none of the patients required pacemaker implantation
and patients were free of tachycardia.
Conclusions: The occurrence of AVNRT in patients with 1st degree AV
block is exceptional and concerns old patients. Ablation of slow pathway
might be safely performed without a need of pacemaker implantation. Transi-
tory 2nd degree AVB can be noted the day after ablation.
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Electrophysiological study is the main method for the detection of patients
with a Wolff-Parkinson-White syndrome (WPW) at risk of adverse presenta-
tion (resuscitated ventricular fibrillation (VF), documented life-threatening
arrhythmia): the protocol is debated. The purpose of the study was to look in
how many patients with WPW-related adverse presentation, atrial fibrillation
(AF) or atrial tachycardia with the shortest RR cycle length (CL) with 1/1
conduction over accessory pathway (AP)<250 msec was induced in control
state (CS) and when isoproterenol was required.
Methods: 63 patients, mean age 38±18, were referred for WPW-related
adverse presentation (VF 6, other 56). EPS included in CS atrial pacing and
measurement of the shortest CL with 1/1 conduction over AP and pro-
grammed stimulation with 1 and 2 extrastimuli. AP effective refractory period
(ERP) was determined. In absence of induction of a tachycardia with a CL
<250 msec, isoproterenol (0.02 to 1 µg. min-1) was infused to increase sinus
rate to 130 bpm; the protocol was repeated.
Results: Mean shortest CL conducted over AP was 223±30 msec in CS,
192±25 msec after isoproterenol. APERP was 225±29 msec in CS, 191±19
msec after isoproterenol. Atrioventricular orthodromic tachycardia (AVRT)
was induced in 34 patients (54%), antidromic tachycardia (ATD) in 13 (21%),
AF in 43 (68%). Criteria for a malignant form (induction of AF or ATD with
a shortest CL <250 mesc) were noted in 42 patients (67%) in CS and were
obtained after isoproterenol in remaining 21 patients (33%). Among these
patients, 12 had inducible tachycardia in CS (AVRT (n=6), ATD (n=3), AF
(n=3) but the shortest CL was >240 msec. A tachycardia was only induced
after isoproterenol in 9 patients (14%).
Conclusions: Infusion of isoproterenol should be systematic when WPW
is evaluated. EPS performed only in CS missed at least 14% of patients at risk
of life-threatening arrhythmias who had no inducible supraventricular tachyar-
rhythmia and 33% of patients with a WPW without the classical criteria for a
malignant form. Isoproterenol increased the sensitivity of EPS for the detec-
tion of malignant form from 67 to 100%.
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Introduction: The Epicor system ® is based on high intensity focused
ultrasound (HIFU) energy used for creating a wide circumferential linear left
atrial lesion encircling both left atrial posterior wall and pulmonary veins (box
lesion) and provides long-term cure in patients with atrial fibrillation under-
going heart surgery. Whether if acute complete disconnection of the box
lesion is achieved by application of HIFU is unknown.
Methods: bipolar pacing and detection into the box lesion was studied in
9 pts (5 men, 77 ±18 yo) undergoing heart surgery (5 aortic valve replacement,
3 mitral valve repair or replacement and one coronary by-pass) using bipolar
electrophysiological catheter and a real time telemetry (Medtronic CareLink®
programmer), just after completion of the ablation process on the beating heart
prior to initiation of extracorporeal circulation. Sinus rhythm was present or
obtained using internal cardioversion in each before the ablation process.
Results: Entrance block was absent in 7 (1 to 1 conduction from sinus
rhythm inside the box lesion), undetermined in one and present in one (disso-
ciated slow local rhythm). Exit block was lacking in 6 (capture of the cardiac
rate by pacing inside the box lesion) and present in 3 (dissociated sinus
rhythm from the paced area).
Conclusion: Acute complete block of the Epicor ® HIFU induced box
lesion is lacking in the vast majority of pts despite completion of the energy
deliverance according to the automated ablation process. Whether block later
happens, or whether supplementary applications would increase the electro-
physiological and clinical success rate is unknown.
192
Treatment of unexplained syncope: A multicenter, randomized trial of
cardiac pacing guided by adenosine 5’-triphosphate testing
Daniel Flammang (1), Timothy Church (2), Luc De Roy (3), Jean Jacques
Blanc (4), Jean Leroy (5), Georges Mairesse (6), Akli Otmani (7), Pierre
Graux (8), Philippe Purnode (9), Robert Frank (10)
(1) Hôpital de La Croix Rousse, Centre de la syncope, Lyon, France –
(2) Minnesota School of Medicine, Division of Environmental Health
Sciences, Minneapolis, Mn, Etats-Unis – (3) Louvain University Hospital,
cardiology, Mont Godinne, Belgique – (4) Brest University Hospital, car-
diology, Brest, France – (5) Gosselies and Gilly Hospitals, cardiology,
Gosselies, Belgique – (6) Arlon General Hospital, Arlon, Belgique –
(7) Georges Pompidou Hospital, cardiology, Paris, France – (8) Saint
Philibert University Hospital, cardiology, Lille, France – (9) Saint Jean
Hospital, cardiology, Brussels, Belgique – (10) La Pitié-Salpêtrière Uni-
versity Hospital, cardiology, Paris, France
